Globus Medical (GMED) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Globus Medical Launches ExcelsiusHub Navigation System
TipRanksNov 22 16:35 ET
Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue?
Yahoo FinanceNov 22 09:15 ET
Express News | Form 144 | Globus Medical(GMED.US) Officer Proposes to Sell 11.04 Million in Common Stocks
Moomoo NewsNov 21 16:35 ET
These 19 Stocks Are Poised for Tax Reform Turbocharge - Jefferies
Seeking AlphaNov 20 16:32 ET
Patterson Companies Stock Up Following Latest Partnership Extension
Zacks Nov 19 09:05 ET
Here's Why You Should Add OMCL Stock to Your Portfolio Now
Zacks Nov 18 07:00 ET

Comments

whqqq

Aug 8 01:51

Arm Holdings, Upstart, Globus Medical Get Analyst Cheer, Retail Bullish On Just Two Names

Retail investors are positive about Upstart and Globus Medical but remain undecided on Arm Holdings as guidance remains sluggish.
Wall Street started Wednesday positively, with major indices rising nearly 1%. Analysts have added to the optimism with upgrades in the semiconductor, financials, and healthcare sectors. Here’s what Bernstein, Citi, and Wells Fargo analysts think:
1. Arm Holdings ( $Arm Holdings (ARM.US)$ ): ...

1

Moomoo AI

Feb 5 19:27

The company's CEO, Dan Scavilla, expressed confidence in Pfeil's ability to drive operational efficiency and deliver profitable growth, especially in light of the ongoing integration following their merger with NuVasive.

Press Release: Globus Medical Promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer

Moomoo AI

Dec 22, 2023 07:10

Globus Medical's superior earnings outlook is contributing to its high P/E, which shareholders are currently comfortable with, expecting not to face a threat to future earnings. The confidence in the future earnings performance supports the current share price.

Why Investors Shouldn't Be Surprised By Globus Medical, Inc.'s (NYSE:GMED) P/E

Moomoo AI

Nov 9, 2023 08:06

Globus Medical's persisting issues impact its valuation and a drop in EPS may spark shareholder worry. The long-term share performance is lackluster, unsettling even potential contrarian investors seeking a turnaround.

Shareholders in Globus Medical (NYSE:GMED) Are in the Red If They Invested a Year Ago

TRIUMPHANT RETURNS

Oct 17, 2023 12:02

on track to 65 ...yeeha.

$SPDR S&P Biotech ETF (XBI.US)$ $Intuitive Surgical (ISRG.US)$ $ResMed (RMD.US)$ $Thermo Fisher Scientific (TMO.US)$ $Boston Scientific (BSX.US)$ $Coinbase (COIN.US)$ $Charles Schwab (SCHW.US)$

GMED Globus Medical

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target